Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients

Clinical trial NCT02201459 · COMPLETED

Trial details

NCT number: NCT02201459
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2014-08-01
Primary completion: 2022-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.